Kadcyla 100 mg Injection (Ado-Trastuzumab emtansine 100 mg)

उत्पाद विवरण

Kadcyla 100mg Injection is administered through an intravenous (IV) infusion under the supervision of a doctor or a nurse, typically in a clinic or hospital setting. It is given once every three weeks, and each infusion session may take around 3090 minutes, depending on individual treatment needs. Attend all scheduled infusion sessions to maintain consistent drug levels for maximum benefits.

Common side effects of Kadcyla 100mg Injection include fatigue, nausea, vomiting, headache, constipation, mild liver enzyme changes, and muscle or joint pain. If you experience nausea, try eating small, frequent meals and avoid heavy or greasy foods. Fatigue can be managed by resting when needed and pacing activities. Let your doctor know if any of these side effects persist or worsen. They may be able to help ways to reduce or prevent the side effects.

Before receiving this medicine, inform your doctor if you have a history of liver or heart issues, as this medication can affect these organs. This treatment is not recommended for pregnant women, as it may harm the unborn baby; women of childbearing age should use effective contraception during treatment and for several months after. Additionally, avoid breastfeeding during and after treatment, as the drug may pass into breast milk.